Stockscreener 앱 받기
1.67
1.21%
0.02
전일 마감가:
$1.65
열려 있는:
$1.65
하루 거래량:
18,847
Relative Volume:
0.12
시가총액:
$74.13M
수익:
-
순이익/손실:
$-28.54M
주가수익비율:
-2.6094
EPS:
-0.64
순현금흐름:
$-22.72M
1주 성능:
-2.91%
1개월 성능:
-5.65%
6개월 성능:
-5.11%
1년 성능:
-73.06%
1일 변동 폭
$1.65
$1.68
1주일 범위
$1.63
$1.72
52주 변동 폭
$1.40
$7.88
Essa Pharma Inc Stock (EPIX) Company Profile
명칭
Essa Pharma Inc
전화
(778) 331-0962
주소
SUITE 720, VANCOUVER, BC
EPIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
1.67 | 74.13M | 0 | -28.54M | -22.72M | -0.64 |
|
ONC
Beigene Ltd Adr
|
235.36 | 24.29B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.42 | 110.94B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3064 | 45.05M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.61 | 61.99B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
73.63 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-11-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-11-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2021-03-04 | 개시 | Piper Sandler | Overweight |
| 2021-01-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-02 | 개시 | Jefferies | Buy |
| 2019-10-25 | 개시 | Oppenheimer | Outperform |
모두보기
Essa Pharma Inc 주식(EPIX)의 최신 뉴스
Cubist Systematic Strategies LLC Buys Shares of 26,287 ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
ESSA Pharma Inc. Explores Strategic Alternatives After Clinical Trial Termination - TipRanks
ESSA Pharma: Fiscal Q2 Earnings Snapshot - CT Insider
ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 - marketscreener.com
ESSA Pharma Reports Q2 2025 Financial Results and Strategic Review - TipRanks
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 | EPIX Stock News - GuruFocus
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Investors who hold shares of ESSA Pharma Inc. (NASDAQ: EPIX) Long - openPR.com
Alis Biosciences Launches To Free Cash From Stalled-Out Biotechs - insights.citeline.com
Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com
Investor pressures struggling Essa to liquidate, give cash to shareholders - Fierce Biotech
ESSA Pharma Inc. (NASDAQ:EPIX): Are Analysts Optimistic? - simplywall.st
We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate - Yahoo Finance
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pha - GuruFocus
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Markets Insider
EPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
ESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
ESSA Pharma Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Business Wire
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pen - GuruFocus
ESSA Pharma Inc. Securities Fraud Class Action Lawsuit - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Shareholders that lost money on ESSA Pharma Inc.(EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire Inc.
ESSA Pharma Inc. Faces Securities Fraud Class Action Over Alleged Investor Misleading Statements - Apna Kal
Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - Longview News-Journal
ESSA Pharma Inc. (NASDAQ: EPIX) Investor Alert: Deadline in Lawsuit on March 25, 2025 - openPR
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm - TradingView
EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of - GlobeNewswire
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIX - TradingView
EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc. - TipRanks
EPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
EPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit - PR Newswire
Levi & Korsinsky Notifies Shareholders of ESSA Pharma - GlobeNewswire
ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire
EPIX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire
Essa Pharma Inc (EPIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
2.08%
자본화:
|
볼륨(24시간):